S&P 500   3,122.82 (+0.08%)
DOW   28,032.28 (+0.10%)
QQQ   203.27 (+0.18%)
BABA   185.56 (+0.04%)
T   39.60 (+0.23%)
ACB   2.31 (-15.36%)
F   8.92 (-0.34%)
BAC   32.98 (+0.15%)
DIS   147.59 (+2.02%)
S&P 500   3,122.82 (+0.08%)
DOW   28,032.28 (+0.10%)
QQQ   203.27 (+0.18%)
BABA   185.56 (+0.04%)
T   39.60 (+0.23%)
ACB   2.31 (-15.36%)
F   8.92 (-0.34%)
BAC   32.98 (+0.15%)
DIS   147.59 (+2.02%)
S&P 500   3,122.82 (+0.08%)
DOW   28,032.28 (+0.10%)
QQQ   203.27 (+0.18%)
BABA   185.56 (+0.04%)
T   39.60 (+0.23%)
ACB   2.31 (-15.36%)
F   8.92 (-0.34%)
BAC   32.98 (+0.15%)
DIS   147.59 (+2.02%)
S&P 500   3,122.82 (+0.08%)
DOW   28,032.28 (+0.10%)
QQQ   203.27 (+0.18%)
BABA   185.56 (+0.04%)
T   39.60 (+0.23%)
ACB   2.31 (-15.36%)
F   8.92 (-0.34%)
BAC   32.98 (+0.15%)
DIS   147.59 (+2.02%)
Log in

Roche Holdings AG Basel Stock Price, Forecast & Analysis (OTCMKTS:RHHBY)

$37.53
+0.19 (+0.51 %)
(As of 11/18/2019 08:53 AM ET)
Today's Range
$37.27
Now: $37.53
$37.58
50-Day Range
$35.31
MA: $36.70
$37.70
52-Week Range
$29.45
Now: $37.53
$37.79
Volume2.91 million shs
Average Volume794,360 shs
Market Capitalization$257.02 billion
P/E Ratio16.18
Dividend Yield1.82%
Beta0.5
Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RHHBY
CUSIPN/A
CIKN/A
Phone41-61-688-1111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$58.12 billion
Cash Flow$2.88 per share
Book Value$4.54 per share

Profitability

Miscellaneous

Employees94,442
Outstanding Shares6,848,490,000
Market Cap$257.02 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter.


Roche Holdings AG Basel (OTCMKTS:RHHBY) Frequently Asked Questions

What is Roche Holdings AG Basel's stock symbol?

Roche Holdings AG Basel trades on the OTCMKTS under the ticker symbol "RHHBY."

What is the consensus analysts' recommendation for Roche Holdings AG Basel?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche Holdings AG Basel in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Roche Holdings AG Basel.

Has Roche Holdings AG Basel been receiving favorable news coverage?

News stories about RHHBY stock have trended very negative this week, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Roche Holdings AG Basel earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Roche Holdings AG Basel.

Who are some of Roche Holdings AG Basel's key competitors?

What other stocks do shareholders of Roche Holdings AG Basel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Roche Holdings AG Basel investors own include Roche Holding Ltd. Genussscheine (ROG), Johnson & Johnson (JNJ), General Electric (GE), Pfizer (PFE), Gilead Sciences (GILD), AbbVie (ABBV), Walt Disney (DIS), Novartis (NVS), Intel (INTC) and Bristol-Myers Squibb (BMY).

Who are Roche Holdings AG Basel's key executives?

Roche Holdings AG Basel's management team includes the folowing people:
  • Dr. Severin Schwan, CEO & Exec. Director (Age 52)
  • Dr. Alan Hippe, Chief Financial & Information Officer (Age 52)
  • Dr. Gottlieb A. Keller, Gen. Counsel & Corp. Sec. (Age 65)
  • Ms. Cristina A. Wilbur, Head of Group HR (Age 52)
  • Dr. Karl Mahler, Head of Investor Relations

Who are Roche Holdings AG Basel's major shareholders?

Roche Holdings AG Basel's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bristol John W & Co. Inc. NY (0.02%), Douglass Winthrop Advisors LLC (0.01%), Riverbridge Partners LLC (0.01%), Ferguson Wellman Capital Management Inc. (0.01%), Grimes & Company Inc. (0.00%) and Kornitzer Capital Management Inc. KS (0.00%).

Which major investors are selling Roche Holdings AG Basel stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS, Chartwell Investment Partners LLC, Scout Investments Inc., Opus Capital Group LLC, Broderick Brian C, Sky Investment Group LLC, MAI Capital Management and Pillar Pacific Capital Management LLC.

Which major investors are buying Roche Holdings AG Basel stock?

RHHBY stock was acquired by a variety of institutional investors in the last quarter, including Douglass Winthrop Advisors LLC, Meritage Portfolio Management, Hikari Power Ltd, Moloney Securities Asset Management LLC, Pacer Advisors Inc., Riverbridge Partners LLC, Bristol John W & Co. Inc. NY and Grimes & Company Inc..

How do I buy shares of Roche Holdings AG Basel?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Roche Holdings AG Basel's stock price today?

One share of RHHBY stock can currently be purchased for approximately $37.53.

How big of a company is Roche Holdings AG Basel?

Roche Holdings AG Basel has a market capitalization of $257.02 billion and generates $58.12 billion in revenue each year. The company earns $10.74 billion in net income (profit) each year or $2.32 on an earnings per share basis. Roche Holdings AG Basel employs 94,442 workers across the globe.View Additional Information About Roche Holdings AG Basel.

What is Roche Holdings AG Basel's official website?

The official website for Roche Holdings AG Basel is http://www.roche.com/.

How can I contact Roche Holdings AG Basel?

Roche Holdings AG Basel's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]


MarketBeat Community Rating for Roche Holdings AG Basel (OTCMKTS RHHBY)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  290 (Vote Underperform)
Total Votes:  546
MarketBeat's community ratings are surveys of what our community members think about Roche Holdings AG Basel and other stocks. Vote "Outperform" if you believe RHHBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHHBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel